GovChime
Archived

NATIONAL CANCER INSTITUTE (NCI) SMALL BUSINESS INNOVATION RESEARCH (SBIR) INNOVATIVE CONCEPT PHASE I AWARD PROGRAM

Overview

Response deadline
5:00 PM EDT
Posted
August 10, 2026
Notice type
Solicitation
Set-aside
Small Business Set Aside - Total
NAICS
NAICS 54171 Research and Development in the Physical, Engineering, and Life Sciences (reported as 541710)
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NIH NCI
Last updated
Oct 28, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
75N98026R00109
Notice ID
5ab4cf48d42c495aabef1d6cdf21acf8

Description

THIS EDIT IS TO POST AMENDMENT #3.  AMENDMENT #3 IS TO provide key questions and answers received in writing by email.


Offerors are required to submit a signed copy of the SF30 Amendment (page 1 only) with their Business Proposal submission.

The deadline for receipt of proposals remains unchanged at 5:00pm, September 21, 2026.

All other terms and conditions of the solicitation remain unchanged.  

PLEASE SEE ATTACHED AMENDMENT #3 PDF.  

_______________________________________________________________________________________________________

THIS EDIT IS TO POST AMENDMENT #2.  AMENDMENT #2 IS TO remove the Data Management Sharing Plan requirement and all references under Sections 5.9 Management and Sharing of Research Data, 6.1 Evaluation Process, Evaluation of Data Management and Sharing Plan, 8.5 Technical Proposal Content (I) Scientific Data Sharing.

The deadline for receipt of proposals remains unchanged at 5:00pm, September 21, 2026.

All other terms and conditions of the solicitation remain unchanged.  

PLEASE SEE ATTACHED AMENDMENT #2 PDF.  

________________________________________________________________________________________________________

ORIGINAL SOLICITATION DESCRIPTION:

The National Cancer Institute (NCI) invites small business concerns to submit research proposals under this Phase I Small Business Innovation Research (SBIR) contract solicitation. Firms with the capability to conduct research and development (R&D) in the health-related topic areas referred to below and described more fully in Section 11.0, and to commercialize the results of that R&D, are encouraged to participate.

The topic areas that are being sought under this solicitation are:

  • Topic 1: Development of therapeutic or preventative technologies for treatment or prevention of Pediatric Cancers and/or Rare Cancers.

For this solicitation rare cancers with a 5-year survival rate of less than 50% are encouraged.

  • Topic 2: Development of devices, diagnostic technologies, or digital health tools for treatment, detection, and diagnosis of Pediatric Cancers and/or Rare Cancers.

For this solicitation, rare cancers with a 5-year survival rate of less than 50% are encouraged.

The National Cancer Institute is soliciting proposals from small business concerns who are looking for an opportunity to perform a few key activities to demonstrate proof-of-concept and feasibility of untested but potentially transformative, game-changing research and development (R&D) technologies to help cancer patients, providers and caregivers, in conjunction with Small Business Innovation Research (SBIR) program objectives. The NCI has established a high-risk, high-reward SBIR “Innovative Concept Award” Program for this purpose.

Preliminary data is not required; however, the ideas should have sound scientific premise either based on the offeror’s own research or literature evidence. Proposals will need to identify an anticipated product that will be developed and clearly lay out the anticipated development path. Proposals will need to clearly identify the clinical problem and cancer type(s) that the proposal will focus on with adequate justification. In addition, the offerors should propose experiments to obtain initial de-risking and proof-of-concept data.

Note: Non-exempt Human subjects research will not be supported under this solicitation.

Phase I Concept Award contractors will be informed of the opportunity to apply for Phase II. Only one Phase II award may result from a single Phase I SBIR contract. The United States Department of Health and Human Services (HHS) is not obligated to make any awards under this solicitation. All awards are subject to the availability of funds. HHS is not responsible for any monies expended by the offeror before award of any contract.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Documents

Files (5)

  • 75N98026R00109 SBIR Phase I - Amendment 0003_FINAL signed.pdf

    359 KBAdded in Solicitation version 8Posted
    Download
  • 75N98026R00109 - Amen 0002_Final.pdf

    653 KBAdded in Solicitation version 5Posted
    Download
  • Attachment_1-Technical_Proposal_Form-NCI_SBIR_FY25_Concept_Award_Solicitation (1).pdf

    1.2 MBAdded in Solicitation version 3Posted
    Download
  • Amendment 0001 - 75N98026R00109.pdf

    674 KBAdded in Solicitation version 3Posted
    Download
  • FY27 NCI SBIR Concept Solicitation Phase I -75N98026R00109.pdf

    789 KBAdded in Solicitation version 2Posted
    Download

Lifecycle

  1. 6
    Version 6PresolicitationArchived

    National Cancer Institute (NCI) Small Business Innovation Research (SBIR) Innovative Concept Award Program – Fiscal Year 2027

    Notice b6f7267813b84393b4b7178dbc9dbd27 on SAM.gov

  2. 2
    Version 2SolicitationArchived

    Type changed from Presolicitation to Solicitation

    NATIONAL CANCER INSTITUTE (NCI) SMALL BUSINESS INNOVATION RESEARCH (SBIR) INNOVATIVE CONCEPT PHASE I AWARD PROGRAM

    Notice 77fae1e382a64e93b4c672ee151b5616 on SAM.gov

  3. 3
    Version 3SolicitationArchived

    NATIONAL CANCER INSTITUTE (NCI) SMALL BUSINESS INNOVATION RESEARCH (SBIR) INNOVATIVE CONCEPT PHASE I AWARD PROGRAM

    Notice 8fbf26c5215646f582bf9fe4b4f00fca on SAM.gov

  4. 4
    Version 4SolicitationArchived

    NATIONAL CANCER INSTITUTE (NCI) SMALL BUSINESS INNOVATION RESEARCH (SBIR) INNOVATIVE CONCEPT PHASE I AWARD PROGRAM

    Notice 3919271f1fd94980bf1f59f3422fd950 on SAM.gov

  5. 5
    Version 5SolicitationArchived

    NATIONAL CANCER INSTITUTE (NCI) SMALL BUSINESS INNOVATION RESEARCH (SBIR) INNOVATIVE CONCEPT PHASE I AWARD PROGRAM

    Notice bfa3aaa08a3947799b2d9771f96c3e32 on SAM.gov

  6. 8
    Version 8SolicitationArchivedCurrent

    NATIONAL CANCER INSTITUTE (NCI) SMALL BUSINESS INNOVATION RESEARCH (SBIR) INNOVATIVE CONCEPT PHASE I AWARD PROGRAM

    Notice 5ab4cf48d42c495aabef1d6cdf21acf8 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75N98026R00109

Archive Date

Oct 6, 2026

Office Address

Bethesda, MD, 20892